Genetic testing in primary care

被引:45
作者
Burke, W [1 ]
机构
[1] Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA
关键词
gene variant; mutation; family history; risk; prevention;
D O I
10.1146/annurev.genom.5.061903.180029
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rapid advances in genetic research are leading to an expanding array of genetic tests. Primary care providers will increasingly be challenged to identify patients whose symptoms, physical findings, or family history indicate the need for genetic testing, and to determine how to use genetic information most effectively to improve disease prevention. In addressing these challenges, practitioners will need to consider the range of different uses of genetic testing, including diagnosis in symptomatic and asymptomatic people, risk assessment, reproductive decision-making, and population screening. They will need a set of core skills and knowledge to evaluate family history and to recognize clinical findings that indicate genetic risk. At the same time, the primary care perspective will contribute to the evaluation of appropriate uses of genetic testing. A partnership between medical genetics and primary care will help to ensure the development of effective policies, educational tools, and practice guidelines for the coming era of genomic health care.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 77 条
[1]  
*AM SOC HUM GEN, 1975, AM J HUM GENET, V27, P240
[2]  
American College of Obstetricians and Gynecologists, 2001, Obstet Gynecol, V97, P1
[3]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[4]   Interest in BRCA1/2 testing in a primary care population [J].
Armstrong, K ;
Weber, B ;
Ubel, PA ;
Guerra, C ;
Schwartz, JS .
PREVENTIVE MEDICINE, 2002, 34 (06) :590-595
[5]   Pharmacogenetic prediction of clozapine response [J].
Arranz, MJ ;
Munro, J ;
Birkett, J ;
Bolonna, A ;
Mancama, D ;
Sodhi, M ;
Lesch, KP ;
Meyer, JFW ;
Sham, P ;
Collier, DA ;
Murray, RM ;
Kerwin, RW .
LANCET, 2000, 355 (9215) :1615-1616
[6]  
Begg CB, 2002, J NATL CANCER I, V94, P1221
[7]   Internet-based risk assessment and decision support for the management of familial cancer in primary care: a survey of GPs' attitudes and intentions [J].
Braithwaite, D ;
Sutton, S ;
Smithson, WH ;
Emery, J .
FAMILY PRACTICE, 2002, 19 (06) :587-590
[8]   Guidelines for diagnosis and therapy of MEN type 1 and type 2 [J].
Brandi, ML ;
Gagel, RF ;
Angeli, A ;
Bilezikian, JP ;
Beck-Peccoz, P ;
Bordi, C ;
Conte-Devolx, B ;
Falchetti, A ;
Gheri, RG ;
Libroia, A ;
Lips, CJM ;
Lombardi, G ;
Mannelli, M ;
Pacini, F ;
Pondder, BAJ ;
Raue, F ;
Skogseid, B ;
Tamburrano, G ;
Thakker, RV ;
Thompson, NW ;
Tomassetti, P ;
Tonelli, F ;
Wells, SA ;
Marx, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5658-5671
[9]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406
[10]   Hereditary hemochromatosis - Gene discovery and its implications for population-based screening [J].
Burke, W ;
Thomson, E ;
Khoury, MJ ;
McDonnell, SM ;
Press, N ;
Adams, PC ;
Barton, JC ;
Beutler, E ;
Brittenham, G ;
Buchanan, A ;
Clayton, EW ;
Cogswell, ME ;
Meslin, EM ;
Motulsky, AG ;
Powell, LW ;
Sigal, E ;
Wilfond, BS ;
Collins, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02) :172-178